For research use only · Not for human use
Semax Sprey
Cognitive and nervous-system research
In short
Semax supplied as a solution in a nasal-spray bottle; no reconstitution needed. Semax is a synthetic 7-amino-acid peptide derived from a fragment of the ACTH hormone.
Evidence level: Approved drug ingredientLicensed as a drug in Russia; not approved in the U.S. or EU. International clinical data is limited.
Size
- Independently tested. Janoshik Analytical results published.
- QR verification. An authenticity code on every box.
Chemistry
| CAS# | Formula | Molar mass |
|---|---|---|
| 80714-61-0 | C37H51N9O10S | 813.9 g/mol |
The current batch certificate for this product is not yet published on the site. Send us your lot number and we'll share it.
Request certificateWhat is Semax Sprey?
Semax is a synthetic heptapeptide derived from ACTH(4-10) with a C-terminal Pro-Gly-Pro extension. This product is the same molecule supplied as a solution in a nasal-spray bottle; unlike the lyophilized vial it needs no reconstitution.
Published preclinical work focuses on BDNF and NGF gene expression, melanocortin receptor binding and monoaminergic signalling. See the Semax (vial) page for background and sources.
Concentration and volume are stated on the label and batch documentation. For research use only.
How should Semax Sprey be stored?
Keep the bottle closed, upright and protected from light. Follow the storage conditions printed on the label.
Buyer reviews
No reviews yet.
Write a review
Related research compounds
References
- Ashmarin IP, et al. The nootropic drug Semax: a review of its mechanisms of action. Neuroscience and Behavioral Physiology. 2005.
- Dolotov OV, et al. Semax regulates BDNF and trkB expression in the rat hippocampus. Brain Research. 2006. PMID 16996037
Semax Sprey is available for laboratory research purposes only.